Page last updated: 2024-11-04

sulfasalazine and Blastocystis hominis Infections

sulfasalazine has been researched along with Blastocystis hominis Infections in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
"hominis in refractory ulcerative colitis."1.37Six ulcerative colitis patients with refractory symptoms co-infective with Blastocystis hominis in China. ( Hu, PJ; Lin, XC; Tai, WP; Wu, J, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tai, WP1
Hu, PJ1
Wu, J1
Lin, XC1

Other Studies

1 other study available for sulfasalazine and Blastocystis hominis Infections

ArticleYear
Six ulcerative colitis patients with refractory symptoms co-infective with Blastocystis hominis in China.
    Parasitology research, 2011, Volume: 108, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiprotozoal Agents; Blastocystis hominis; Blastocy

2011